Molecular biology · Bioinfo & AI
Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer
This study investigated the potential of enhancer RNAs (eRNAs) as biomarkers for breast cancer, complementing traditional protein-coding transcripts. By profiling eRNA expression across over 1000 TCGA-BRCA samples and healthy tissues, researchers developed a 10-eRNA signature that effectively stratified patients into high- and low-risk groups, demonstrating independent prognostic value. Furthermore, a 19-eRNA panel was designed for early detection, showing excellent performance on an independent cohort. These tools have been integrated into eRNACare, a publicly accessible web application, highlighting the promising role of eRNAs for breast cancer risk stratification, therapeutic guidance, and early diagnosis.